Gc MAF (Gc Protein derived Macrophage Activating Factor)

The treatment with GcMAF is an effective method for strengthening the immune system, based on the activation of macrophages. Approaching treatment for bacterial and viral infections, autism, and autoimmune diseases. This innovative therapy is geared towards stimulating the body's natural defense mechanisms, enabling macrophages to actively identify and eliminate cancer cells and other pathologically changed cells. Through this approach, GcMAF aids the fight against diseases on a cellular level, offering promising perspectives for the treatment of various types of cancer and improving overall health condition.

What is Gc-MAF (Macrophage Activating Factor)?

GcMAF, known as a macrophage activating factor derived from Gc protein, is a key natural substance in the human body, prompting macrophages to attack cancer cells and invasive agents such as bacteria and viruses. Significant health issues like cancer, HIV, and viral hepatitis can lead to a depletion of GcMAF, thus weakening the immune system's defenses and facilitating the unchecked spread of diseases. This substance plays a vital role in maintaining immune balance, helping to neutralize pathogens and malignant cells, which is critically important for disease prevention in the body.

How does Gc MAF work?

Activation of Macrophages: GcMAF stimulates macrophages – a type of white blood cells that devour and destroy cancer cells, viruses, bacteria, and other pathogens. This enhances the immune system’s ability to identify and eliminate harmful agents.

Enhancement of Immune Response: Through the activation of macrophages, GcMAF facilitates the enhancement of the overall immune response of the body. This includes increasing the production of antibodies and other vital cytokines, which aid in combating infections and preventing the spread of diseases.

Regulation of the Immune System: GcMAF assists in restoring the balance in the immune system, which is especially important in autoimmune diseases and chronic conditions where the immune system may react excessively or inadequately.

Acceleration of Recovery: It aids the healing process in the body after infections or other diseases, speeding up the elimination of pathogens and the restoration of affected tissues.

Synergy with Other Therapies: Gc MAF can be used in combination with other types of treatment, such as targeted therapies, without diminishing their effectiveness. In some cases, it can even enhance their action by improving the immune response of the organism.

It is important to note that while there are encouraging data on the potential of Gc-MAF, the scientific community continues to research its effectiveness and safety in various diseases. For this reason, therapy with GcMAF should be undertaken under the supervision of a qualified medical specialist.

What are the main goals of the therapy with GcMAF?

Improving the well-being and quality of life.
Restoring the patient to a better health condition, enabling engagement in regular activities.
Enhancing the effects of other therapies.
Restoring the immune system.
Increasing the number of monocytes (macrophages) and their activation to destroy cancer cells, viruses, bacteria, and other pathogens in the body.
Accelerating the process of maturation of dendritic cells.

For which conditions can Gc-MAF therapy be beneficial?

Cancerous Diseases: GcMAF stimulates macrophages to identify and destroy cancer cells, which can help in preventing the spread of cancer and support the effectiveness of other therapies.

Viral Infections: The therapy is used to combat viral diseases such as HIV and hepatitis, enhancing the body's ability to fight viruses.

Chronic Infections: It may improve responses of the immune system in chronic bacterial and viral infections, which traditional treatments struggle to control.

Autoimmune Diseases: Gc-MAF is being investigated for its potential to regulate the immune system and to reduce inflammation in autoimmune conditions, although further studies are needed.

Neurological Diseases: Preliminary evidence suggests that Gc MAF can improve neurological functions in conditions like autism and chronic fatigue, aiding in restoring normal immune function.

It is important to note that while there are promising results in some studies, the efficacy and safety of GcMAF are still being researched, and therapy should only be undertaken after consultation with a qualified medical specialist.

Administration and Dosage of Gc-MAF:

One unit of a 3600 ng pen is equal to 12 ng. One unit of a 6000 ng pen is equal to 20 ng. One unit of a 12000 ng pen is equal to 40 ng. Storage conditions: Between 2 and 8 degrees Celsius.

Dosage and administration for autism:

First week: 300 ng. 3 times per week.
From the second week until the end of treatment: 600–700 ng. 3 times per week.
Duration of intake: 6 months.
The dose can be increased to 1200–1500 ng depending on the patient’s immune responses.
To be combined with VITAMIN D3 from 2000 IU to 10000 IU daily.

Dosage and administration for cancer patients:

First week: 300 ng. 2 times per week.
Second week: 600–700 ng. 2 times per week.
From the third week until the end of treatment: Between 1200 ng and 1500 ng. 2 times per week.
To be combined with VITAMIN D3 from 2000 IU to 10000 IU daily.

Examples: 300 ng = 25 units ; 600 ng = 50 units ; 1200 ng = 100 units

Peptides for Immune System

Gc MAF | Gc Protein derived Macrophage Activating Factor